lecture 8 - Immunotherapy Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

What principles are immunosurveillance built on?

A

Self-tolerance - B and T cells against self-antigens are discarded prior to maturation to avoid autoimmunity
Immunity against foreign (non-self) antigens to generate an immune response
However, in cancer we need self-immunity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How do tumour neo-antigens arise?

A

Cancer cell mutations can lead to abnormal proteins that can be broken up into peptides
These peptides can be perceived as non-self and generate an immune response if they are displayed on the surface of the cancer cell
Neo-antigens need to be presented by MHC on the cell surface
However, the immune system can paradoxically constrain and promote tumour development and progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the three phases of cancer immunoediting?

A

Elimination, equilibrium and escape
Cancer immunoediting happens during cancer progression, but also in patients receiving anticancer immunotherapies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the elimination phase of cancer immunoediting?

A

Tumours are recognised and eliminated by the innate and adaptive immune response
Macrophages and NK cells can recognise and kill cancer cells
T cells and antibodies (B cells) recognise tumour-associated antigens - CD8 cytotoxic T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How do natural killer cells play a role in the elimination phase?

A

NK cells are part of the first line of defence against tumour cells and their activation depends on activating and inhibitory signals received from cell surface receptors
Normally, NK cell activation is inhibited by ligands expressed on healthy cells that bind to inhibitory receptors on NK cells
A reduction in the expression of these ligands or an up regulation of stress-induced ligands that can occur in tumour cells leads to NK cell activation, and results in the production of IFN-gamma and direct cytotoxic activity against these cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How do Th1, 2 and 17 cells play a role in the elimination phase?

A

Th1 cells are a subset of effector CD4 cells whose differentiation is activated by IL-12
They are mainly involved in macrophage activation, but can also suppress Th2 responses and promote cell mediated cellular cytotoxicity
Th2 - initiate B cells to produce antibodies and promote mast cell and eosinophil function, suppresses Th1 responses
Th17 - a subset of CD4 T cells which secretes IL-17, which in turn promotes recruitment of neutrophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How do cytotoxic T cells play a role in the elimination phase?

A

CD8+ are a T cell type that can induce cell killing
they create holes into the membrane of the target cell, lysing the cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the equilibrium phase of cancer immunoediting?

A

Rare tumour sub clones with further mutations survive elimination, and the tumour progresses into the equilibrium phase
this is where selection pressures instigate new tumour cell genetic variants
Net tumour growth is limited and can be stalled

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the escape phase of cancer immunoediting?

A

Can select for tumour subclones with reduced immunogenicity that can evade immune recognition and destruction (e.g. decrease in IFNg secretion)
There is an up regulation of surface molecules
CD8+ T cells become exhausted or dysfunctional due to persistent antigen exposure and chronic T cell receptor signalling
Characteristics of exhausted T cells include up-regulated and sustained expression of multiple inhibitory immune checkpoint receptors, reduced proliferation and decreased production of effector cytokines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which immune cells are tumour-promoting and which are tumour-suppressing?

A

Promoting - Treg cells, M2 macrophages, MDSC
Suppressing - NK cell, M1 macrophage, dendritic cell, B cell, TRM cell, CD4+ T cell and CD8+ T cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the difference between M1 and M2 macrophages?

A

M1s are pro-inflammatory - they are present at the elimination phase and keep the tumour in check
M2s are resolving macrophages - they do not attack the cancer cells, but they support the environment that helps the tumour cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the function of Tregs?

A

Subset of CD4+ T cells - they have immunosuppressive properties that are important for maintaining immune homeostasis and self-tolerance, limiting inflammation and preventing autoimmunity
They also inhibit multiple immune cell types including CD8+ and CD4+ effector T cells, NK cells and DCs
In cancer, Tregs inhibit the anti tumour immune response through inhibition of tumour-suppressing immune cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the roles of myeloid-derived suppressor cells?

A

MDSCs are a population of immature myeloid cells with immunosuppressive properties
They produce high levels of IL-10, TGF-beta and other cytokines which inhibit NK cells, CD8+ and CD4+ cells, and promote expansion of regulatory T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are hot and cold tumours?

A

Hot tumours have high levels of tumour-infiltrating lymphocytes
Cold tumours contain high levels of immunosuppressive cells
Hot tumours often have a high mutational load - this means they often have higher levels of neoantigens that can be recognised by the immune system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the aim of immunotherapy?

A

To get more immunosuppressive cells and less of the promoting ones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How can interleukin-2 and Interferon-a be used as therapies?

A

Multiple actions including stimulation of T cells to proliferate
treatment of advanced kidney cancer
adjuvant with some vaccines

Suppression of immune inhibiting T-reg
treatment of multiple cancers
Has side effects such as flu-like symptoms and an increased risk of infection

17
Q

How can mAB therapies be used?

A

Can have antibodies that might be linked and conjugated to a toxin
E.g. an antibody which has chemotherapy attached to the Her2 receptor

18
Q

How can immune checkpoint inhibitors be used as therapies?

A

Immune checkpoints are regulators of the immune system for self-tolerance
The idea is to interrupt the interaction between the PDL-1 and PD1, so the immune cells can detect the cancer cells
Ipilimumab inhibitors CTLA4
Durvalumab targets PDL1
Pembrolizumab and Nivolumab target PD1-specific antibody

19
Q

How does adoptive cell transfer work?

A

General: Take immune cells from a patient and provide a chimeric receptor that allows them to target the tumour cells more effectively
Chimeric antigen receptor (CARs) -combines in a single chimeric protein, the recognition domain of a specific antibody against a tumour-associated antigen and an intracellular signalling domain capable of activating T cells

20
Q

What is a disadvantage to adoptive cell transfer?

A

It is a very expensive therapy as the T cells have to be extracted and genetically modified
they need to be able to be injected back into the patient and survive - may not be possible in an immunosuppressive environment

21
Q

What are some potential future ways of making a tumour hot?

A

Improve T cell priming, can use adoptive T cell therapy
T-cell trafficking might be a problem (the migration) - might need to overcome barriers